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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORMucosa-associated lymphoid tissue lymphoma
on the mouth floor presenting with Sjo¨gren’s
syndrome and giant cell tumor of spinal tendonDear Editor,
Most MALTomas [malignancies that occur in mucosa-
associated lymphoid tissue (MALT)] are classified as low
grade non-Hodgkin lymphomas, constituting approximately
5e10% of this disease as a whole [1]. MALTomas can occur in
any extranodal site, but most commonly in the gastroin-
testinal tract. Salivary gland MALTomas usually occur in the
parotid gland [1]. We have found only seven well-
documented cases of MALTomas of the mouth floor in the
literature [2,3].
Here, we report a case of mouth-floor MALToma in a 54-
year-old female. In July 2009, she visited our clinic pre-
senting with a mass on the mouth floor that had lasted for
1 month. The size of the mass did not change significantly
or fluctuate with food intake. The patient did not complain
of local pain or body weight loss, but she did confirm having
symptoms of dry eye and dry mouth for years. Primary
Sjo¨gren’s syndrome was diagnosed based on positive anti-
SSA/Ro serology and a positive Schirmer’s test. A physical
examination confirmed a nonmovable mass, measuring
approximately 1.2 cm  0.8 cm in size, on the left mouth
floor. A magnetic resonance imaging showed a well-defined
homogeneous mass with a low-signal intensity (Fig. 1A). A
wide excision of the tumor was performed. A pathological
examination found the mass to be a MALToma with a safety
margin of 2 mm (Fig. 1B). The staging was IE according to
the Ann Arbor staging system. She was then referred to our
oncology department with no further requirement of
postoperative management. According to her medical his-
tory, she had previously received a positron emission
tomography-computed tomography (PET-CT) scan, pan-
endoscopy, and colonoscopy during a health check-up in1607-551X/$36 Copyright ª 2013, Kaohsiung Medical University. Publish
http://dx.doi.org/10.1016/j.kjms.2013.04.006February 2009. The PET-CT scan showed only a hot spot
over the lumbar spine region at the L5/S1 level (Fig. 1C). A
right paraspinal tumor of L5/S1 was suspected and the
tumor was excised by a neurosurgeon in January 2010.
Pathological analysis showed the removed mass to be a
giant cell tumor. She received follow-up care in our hospi-
tal, with no evidence of MALToma recurrence observed to
date.
MALTomas in salivary glands are characterized by a close
comorbidity with Sjo¨gren’s syndrome (46% according to the
literature) [1]. Mariette hypothesized that the develop-
ment of lymphoma could be related to chronic immune
stimulation. Polyclonal B cells secrete rheumatoid factor
(RF) in the salivary glands, which are affected by Sjo¨gren’s
syndrome. These RF B cells become monoclonal and
disseminate into other organs. Monoclonal B-cell-secreted
RF complexes with polyclonal immunoglobulin G cry-
oprecipitate contribute to chromosomal abnormalities,
which may later transform into MALTomas [4].
Treatment depends on the lesion site and stage. Ac-
cording to the National Comprehensive Cancer Network
Clinical Practice Guidelines [5], patients with localized
lymphomas (Stages IE and II) should be treated with sur-
gery, supplemented with loco-regional radiotherapy of
20e30 Gy if the margin is positive. In recurrent or advanced
stages of the disease (Stages III and IV), radiotherapy and
chemotherapy are suggested.
MALTomas have a good prognosis, with a 5-year overall
survival rate of approximately 86e100%. Nevertheless, the
high rate of late relapses (37%) makes lifelong observation
necessary. In one case of mouth-floor MALToma (stage IE),
partial relapse was reported 70 months after chemotherapy
had ended [3].ed by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) A well-defined, low-signal mass (arrows) measuring approximately 2.2 cm  1 cm in size located over the anterior
aspect of the left sublingual space in a T2-weighted axial image. (B) Salivary gland tissue with a dense infiltrate of small lymphoid
cells as well as hyperplasia of lymphoid follicles. The architecture of the salivary glands has been destroyed, resulting in confluent
lobular structures. Most acini are replaced by lymphoid cells and only some tortuous ducts infiltrated by lymphocytes are noted
(hematoxylin and eosin stain, 400). (C) A positron emission tomography-computed tomography showed only a hot spot over the
lumbar spine region at the L5/S1 level.
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